All the news Showing 10 of 63 articles from: Hepatocellular carcinoma (HCC)Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Antihistamine use halved the risk of liver cancer in people with viral hepatitis Keith Alcorn / 08 February 2022 Antihistamines used for relief of allergies and hay fever halved the risk of developing hepatocellular carcinoma (HCC; liver cancer) in people with viral hepatitis during a ten-year follow-up period, a review of ... Some people remain at risk for liver cancer despite hepatitis C treatment Liz Highleyman / 22 December 2021 Some people with liver cirrhosis remain at risk for developing hepatocellular carcinoma (HCC) even after hepatitis C treatment, according to study results presented at The Liver Meeting. Not achieving a cure was the biggest ... Antiviral treatment for hepatitis C virus reduces risk of post-treatment liver cancer progression Medical Xpress / 13 December 2021 Japanese study shows benefits of treating hepatitis C early Keith Alcorn / 24 August 2021 Curing hepatitis C in people with mild fibrosis by the age of 50 reduces their risk of death to the same level as the rest of the population, Japanese researchers report in ... Liver cancer surge as study shows Scotland has highest rates in UK The Herald / 07 April 2021 Pancreatic and colorectal cancer risk raised in people with hepatitis C Keith Alcorn / 16 March 2021 Pancreatic cancer occurred more often in people with hepatitis C or HIV in Canada’s British Columbia Hepatitis Testers Cohort, and colorectal cancer was more likely to occur in people diagnosed with hepatitis ... Liver Stiffness Before Hepatitis C Treatment Predicts Liver Cancer Risk Hep Mag / 18 January 2021 HCV-Related Liver Cancer Incidence Dropped in US Cohort Medscape / 28 September 2020 Models can help predict liver cancer in people cured of hepatitis C Liz Highleyman / 17 September 2020 Three new methods using readily available clinical parameters can help predict who will develop hepatocellular carcinoma (HCC) after achieving sustained virological response to hepatitis C treatment, according to studies presented at the recent 2020 Digital ... Immunotherapy combinations show promise for advanced liver cancer Liz Highleyman / 02 September 2020 Three checkpoint inhibitor immunotherapy regimens show promise for people with hepatocellular carcinoma (HCC), the most common type of liver cancer, according to a set of late-breaking presentations last week at the 2020 Digital ... ← First12345...7Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive